1. 1. Cruz M.P.: Vilazodone HCl (Vibryd): A serotonin partial agonist and reuptake inhibitor for the treatment of major depressive disorder, P. & T., 2012, 37 (1) 28-31.
2. 2. Schwartz T.L.; Siddiqui U.A. and Stahl S.M.: Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor, Ther. Adv. Psychopharmacol., 2011, 1 (3) 81-87.
3. 3. Ghosh S., Bomma, S., Prasanna, V.L. and Banji D.: Development of validated UVspectrophotometric method for the estimation of vilazodone hydrochloride, Int. J. Drug Dev. & Res., 2014, 6 (1)169-174.
4. 4. Panda S.S., Ravi Kumar B.V.V., Beg S. and Behera S.: Spectrophotometric quantification of vilazodone hydrochloride in pharmaceutical dosage form using quality by design approach, Malaysian J. Anal. Sci., 2015, 19 (5) 920-929.
5. 5. Ravisankar P., Gowthami S., Devadasu, C.H., Srinivasa Babu P. and Reddy P.V.: A novel validated RP-HPLC method for the estimation of vilazodone in bulk and pharmaceutical dosage form, Am. J. PharmTech Res., 2014, 4 (5) 670-682.